Tuesday, 14 December 2010

UPDATE 2-Teva multiple sclerosis pill shines in big study


From Reuters:
Teva Pharmaceutical Industries (TEVA.TA) (TEVA.O) expects its pill-based treatment for multiple sclerosis to receive U.S. regulatory approval within two years after a clinical trial met its main goal, it said on Thursday.  For more click here.